Industry insight series - From molecule to market @SiemensSoftware
Industry insight series - From molecule to market  @SiemensSoftware
Uploaded October 2026 | Updated November 2026, 5 days ago
How can pharmaceutical and life sciences companies move from molecule to market faster – without adding risk?

See how Siemens and AWS technologies are helping pharmaceutical and life sciences organizations move beyond siloed digital transformation to connect data, workflows, and decision-making across the development lifecycle.

From Agentic AI and Native Cloud to digital twins and simulation, discover three shifts helping organizations:
• Connect scientific data and knowledge across the digital thread
• Model and evaluate products, processes, and facilities before investing in the physical world
• Increase agility and derisk future investments


#LifeSciences #AgenticAI #DigitalTwin #SiemensXcelerator #AWS
Industry insight series - From molecule to marketBreaking Simulation Barriers: HPC for Next-Gen Power ElectronicsSmarter Instancing in S-Edit with Multiple NamesTony Hemmelgarn: On the need for AI to narrow the variation space in GPU verificationWhats new in Simcenter 3D 2606 | Motion | Graphical topology mapping updates #WhatsNewSimcenterAI in electrical engineering: AI assisted design interrogation and modificationThe access-control gap hiding in your PCB design dataWhat’s New in Xpedition 2610: Design Creation UpdatesCommunication, Trust, Process | Printed Circuit Podcast Episode 42Plant Simulation Virtual User Group: Various pull control methodsFrom PCB geometry to S-parameters in minutes with HyperLynx Advanced SolversMedical device product lines: 150% BOM for variant management and compliance
Siemens Software |

Industry insight series - From molecule to market

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER